Daré Bioscience, Inc.

Healthcare · Biotechnology · United States

Last price 0.6815 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 13.40M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia for the treatment of female sexual arousal disorder; DARE-HRT1 to treat vasomotor sympto...